TickerGuard
Buy Day today: Poor (44) Weak market breadth · today: Core PCE (August) ≈
RNTX

Rein Therapeutics Inc

Healthcare · Biotechnology

0.7703$ -3.1% vs. previous close Closing price · As of: Sep 23, 2026

Statements

Income Statement

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Income Statement RNTX
Line item 2020 2021 2022 2023 2024 2025
– – – – – –
– – – – – -98.4%
– – – – – –
– +52.3% +5.6% -77.8% +356,903.3% -22.6%
– +2.9% +0.9% +17.3% +121,974.5% -21.4%
– +29.8% +3.9% -41.1% +399,949.2% -66.3%
– – – – – –
– – – – – –
– – – – – –
– – – – – –
– – – – – –

Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?